483 GlaxoSmithKline Biologicals SA Oct 2014

483 GlaxoSmithKline Biologicals SA Oct 2014

Debra Emerson FDA, Omotunde Osunsanmi FDA$119.00 - Available Now

FDA investigators audited the GlaxoSmithKline Biologicals SA - Rixensart, Belgium facility and issued inspectional observations (via FDA 483) on 02 Oct 2014.

Product details

  • Category: Biologics
  • Inspection end: 02 Oct 2014
  • Location: Rixensart, Belgium
  • FEI: 3002875226
Add To Cart